Replimune, which was seeking approval of RP1 in combination with Bristol Myers Squibb's Opdivo for the treatment of advanced melanoma, on Tuesday said the FDA issued a so-called complete response ...

Replimune (NASDAQ:REPL) announced on Tuesday that the U.S. Food and Drug Administration (FDA) issued a Complete Response ...

Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that the U.S. Food and Drug Administration ...

Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that it has entered into a ...

Proposals include establishing "indirect recognition" of EU CE-marked devices to the UK market and "international reliance" ...

The FDA granted an orphan drug designation to novel hedgehog pathway inhibitor taladegib, also known as ENV-101, for treating ...

Certain YoCrunch yogurt products were taken off Guam shelves as a result of a voluntary product recall due to possible plastic contamination.

Many reusable menstrual products that have gained increasing popularity among teens are packed with toxic “forever chemicals, ...

Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the ...

Philip Morris International Inc. lifted its full-year profit guidance, as US sales of its Zyn nicotine pouches and IQOS ...

PRNewswire/ - Medunik USA, a specialty pharmaceutical company dedicated to providing rare disease patients with access to ...

More people are starting to use AI chatbots for therapy, but experts are warning users to still keep human therapists in the loop.